{"title": "Canal SEMI COVID-19 para Profesionales", "author": null, "url": "https://www.fesemi.org/canal-semi-para-profesionales-covid-19", "hostname": "fesemi.org", "description": null, "sitename": "fesemi.org", "date": "2020-04-17", "cleaned_text": "Canal SEMI COVID-19 para Profesionales Bienvenido/a al canal COVID-19 para profesionales de la Sociedad Espa\u00f1ola de Medicina Interna (SEMI). Este espacio pretende servir de punto de encuentro entre internistas para compartir informaci\u00f3n sobre el coronavirus, as\u00ed como para plantear consultas e intercambiar datos que puedan ser de utilidad al conjunto de los profesionales de la SEMI en estos momentos. Adem\u00e1s de poder compartir documentos, protocolos, an\u00e1lisis e impresiones, a trav\u00e9s de los siguientes enlaces puedes acceder a: - [informaci\u00f3n en tiempo real de la evoluci\u00f3n de la emergencia sanitaria declarada en Espa\u00f1a por el COVID-19](https://covid19.isciii.es/) (por CC.AA.) - [documentos t\u00e9cnicos](https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos.htm) del Ministerio de Sanidad para profesionales sanitarios. -\u00faltimos [informes diarios](http://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx) sobre la pandemia en Espa\u00f1a del Instituto de Salud Carlos III (ISCIII). Este canal nos permitir\u00e1 estar coordinados e informados sobre todo lo relacionado con el coronavirus (Covid-19). A trav\u00e9s de estos enlaces, podr\u00e1 acceder a los canales de [The New England Journal of Medicine](https://lnkd.in/eCqwmu6), [The BMJ](https://www.bmj.com/<span class='finded'>coronavirus), [The Lancet](https://lnkd.in/ecvvMH9), y [JAMA.](https://lnkd.in/eAHguDq) Adem\u00e1s, puedes acceder en abierto, a la edici\u00f3n en espa\u00f1ol del [mini-manual de Kamps&Hoffman sobre COVID-19](https://covidreference.com/es) con informaci\u00f3n recopilada sobre epidemiolog\u00eda, virolog\u00eda, inmunolog\u00eda, diagn\u00f3stico y manifestaci\u00f3n cl\u00ednica de la enfermedad por SARS-CoV-2, entre otros muchos aspectos. Edici\u00f3n del 29 de marzo de 2020. Para acceder a todas las funcionalidades de est\u00e1 p\u00e1gina, recuerde que deber\u00e1 estar identificado en la web con sus credenciales de socio de SEMI (usuario y contrase\u00f1a). [ACCEDE AL FORO PARA PROFESIONALES DE SEMI](https://www.fesemi.org/foros/canal-profesional-covid-19-semi) Documentos t\u00e9cnicos, protocolos y esquemas terap\u00e9uticos recopilados por SEMI y sus entidades miembro sobre COVID-19. -DOCUMENTOS OFICIALES: MINISTERIOS, COMUNIDADES AUT\u00d3NOMAS (CC.AA.) Y OTROS ORGANISMOS DE LA ADMINISTRACI\u00d3N Actualizaci\u00f3n de la Estrategia de Vacunaci\u00f3n frente a COVID-19. Preguntas y respuestas frecuentes. Abril de 2021 Una visi\u00f3n global de la pandemia COVID-19: qu\u00e9 sabemos y qu\u00e9 estamos investigando desde el CSIC Estudio ENE-COVID19: Infome final. Estudio Nacional de Sero-epidemiolog\u00eda de la infecci\u00f3n por SARS-CoV-2 en Espa\u00f1a. 6 de julio de 2020 Estudio ENE-COVID19: Segunda ronda Estudio Nacional de Sero-epidemiolog\u00eda de la infecci\u00f3n por SARS-CoV-2 en Espa\u00f1a. Informe preliminar a fecha 3 de junio de 2020 Clinical Management of COVID-19. OMS-WHO. 27 de mayo de 2020 Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19 Tratamientos disponibles para el manejo de la infecci\u00f3n respiratoria por SARS-CoV-2 Informaci\u00f3n Cient\u00edfico-T\u00e9cnica. Enfermedad por Coronavirus COVID-19. Actualizaci\u00f3n a 18 de mayo de 2020 Estudio ENE-COVID19: Primera ronda Estudio Nacional de Sero-epidemiolog\u00eda de la infecci\u00f3n por SARS-CoV-2 en Espa\u00f1a. Informe Preliminar a fecha 13 de mayo de 2020 Informe sobre la situaci\u00f3n de COVID-19 en Espa\u00f1a. 7 de mayo de 2020 Estrategia de Diagn\u00f3stico, vigilancia y control en la fase de transici\u00f3n de la pandemia de COVID-19. Indicadores de seguimiento. 6 de mayo de 2020 Coronavirus Disease 2019 (COVID-19). Medical Virology: from Pathogenesis to Disease Control COVID-19. Recomendaciones sanitarias para la estrategia de transici\u00f3n. CCAES. Ministerio Sanidad. 25 de abril de 2020 Cloroquina/Hidroxicloroquina: precauciones y vigilancia de posibles reacciones adversas en pacientes con COVID-19.22.04.20 Interpretaci\u00f3n de las pruebas diagn\u00f3sticas frente a SARS-CoV-2. 22 de abril de 2020 Coronavirus disease 2019 (COVID-19) Situation Report - 84. OMS. Instrucciones de la AEMPS para el uso compasivo de Tocilizumab (TCZ) Prevenci\u00f3n y control de la infecci\u00f3n en el manejo de pacientes con COVID-19. Versi\u00f3n 14 de abril EPICOS - Ensayo Cl\u00ednico para la Prevenci\u00f3n de la Infecci\u00f3n por Coronavirus en Sanitarios Gu\u00eda para la utilizaci\u00f3n de test r\u00e1pidos de anticuerpos para COVID-19. Ministerio de Sanidad COVID-19. EU recommendations for testing strategies. Comisi\u00f3n Europea. La AEMPS informa sobre el buen uso de medicamentos relacionados con COVID-19 Gu\u00eda para la utilizaci\u00f3n de test diagn\u00f3sticos para COVID-19. 6 de abril de 2020 Informaci\u00f3n Cient\u00edfica-T\u00e9cnica. Enfermedad por Coronavirus (COVID-19). Actualizaci\u00f3n, 4 de abril de 2020 Procedimientos de actuaci\u00f3n frente al COVID-19 en Asturias. Protocolo general. 1 de abril Procedimiento de actuaci\u00f3n frente a casos de infecci\u00f3n por el nuevo Coronavirus SARS-CoV-2. Actualizado a 31 de marzo Gu\u00eda de actuaci\u00f3n frente a COVID-19 en los profesionales sanitarios y sociosanitarios. Versi\u00f3n 31 de marzo Recomendaciones de la AEMPS para la gesti\u00f3n de medicamentos para el manejo de pacientes en fase terminal Recomendaciones para el manejo, prevenci\u00f3n y control de COVID-19 en Unidades de Di\u00e1lisis. Versi\u00f3n de 25 de marzo de 2020 Procedimiento de actuaci\u00f3n para los servicios de prevenci\u00f3n de riesgos laborales frente a la exposici\u00f3n al SARSCoV2. 30 de marzo de 2020 Informe del Comit\u00e9 de Bio\u00e9tica de Espa\u00f1a sobre los aspectos bio\u00e9ticos de la priorizaci\u00f3n de recursos sanitarios en el contexto de la crisis del coronavirus Informe sobre la incidencia del COVID-19 en Espa\u00f1a. Actualizaci\u00f3n n\u00famero 57. Ministerio de Sanidad. CCAES. Informaci\u00f3n Cient\u00edfico-T\u00e9cnica de la enfermedad por Coronavirus COVID-19. CCAES. Ministerio de Sanidad. Actualizaci\u00f3n 26 de marzo de 2020 Tratamientos disponibles para el manejo de la infecci\u00f3n respiratoria por SARS-CoV-2. AEMPS. 26 de marzo Manejo cl\u00ednico del COVID-19: tratamiento m\u00e9dico. Ministerio de Sanidad La AEMPS informa de la distribuci\u00f3n controlada de todo el stock de hidroxicloroquina-cloroquina Gu\u00eda de prevenci\u00f3n y control frente al COVID-19 en residencias de mayores y otros centros de servicios sociales de car\u00e1cter residencial Actualizaci\u00f3n N\u00ba 52. Enfermedad por el coronavirus (COVID-19). 22.03.2020 Informe Fake News y desinformaciones sobre el virus COVID-19 en fuentes abiertas Protocolo de derivaci\u00f3n de pacientes con COVID-19 a hoteles sanitarizados de la Comunidad de Madrid. Manejo cl\u00ednico del COVID-19: atenci\u00f3n hospitalaria Manejo de la mujer embarazada y el reci\u00e9n nacido con COVID-19 Procedimiento de atenci\u00f3n y seguimiento domiciliario de casos posibles y confirmados por SARS-CoV-2 (COVID-19) Toma y preparaci\u00f3n de las muestras biol\u00f3gicas en domicilio en casos en investigaci\u00f3n por SARS-CoV-2 Medicamentos antihipertensivos que act\u00faan sobre el sistema renina angiotensina e infecci\u00f3n por COVID-19 La AEMPS informa que ning\u00fan dato indica que el ibuprofeno agrave las infecciones por COVID-19 Gu\u00eda de actuaci\u00f3n con los profesionales sanitarios en el caso de exposiciones de riesgo a COVID-19 en el \u00e1mbito sanitario Bolet\u00edn Oficial del Estado (BOE). 15 de marzo de 2020. -EPIDEMIOLOG\u00cdA, TRANSMISI\u00d3N Y PATOG\u00c9NESIS: Virology, transmission, and SARS-CoV-2 Drives Development of COVID-19 COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses Tail risk of contagious diseases Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset Epidemiology of and Outpatients State, March 1-April 16, 2020 SARS-COV-2 was already spreading in France in late December 2019 A cohort of patients with COVID-19 in a major teaching hospital in Europe The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: infection facilitates the rapid Time Must Be Different: Disparities During the COVID-19 Pandemic COVID-19 Epidemic: Exercise; That is the Question! of contact tracing on transmission Respiratory the Achilles' Covid-19 Global Virology Virology in the Century The convalescent sera for containing COVID-19 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. Meeting the Care against disease 2019 and influenza in Hong Kong: an observational study Covid-19 and Immunity in Aging Populations \u2014 A New Research Agenda Spread of SARS-CoV-2 in the Icelandic Population COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020 Temporal dynamics in viral shedding and transmissibility of COVID-19 Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period The Mental Health Consequences of COVID-19 and Physical Distancing A Sneeze Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review (Review) Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 - first control with digital contact tracing Early dynamics of transmission and control of COVID-19: a mathematical modelling study COVID-19 Science Report: syndrome coronavirus 2 the USA Ten Weeks to Crush the Curve Modelizaci\u00f3n Epidemiol\u00f3gica del Covid-19 para Espa\u00f1a Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, with Coronavirus Disease 2019 \u2014 United States Timely research papers about COVID-19 in China The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Responding to the in complex humanitarian crises Patients with respiratory symptoms are at greater risk of COVID-19 transmission Canadian Geriatrics Society COVID-19 Recommendations for Mass masking in the COVID-19 people need guidance How will country-based mitigation Inhibitor. Revista Cell Novel Coronavirus-Infected Pneumonia COVID-19: Una propuesta de estadificaci\u00f3n cl\u00ednico-terap\u00e9utica. Journal Transplantation Report sulle caratteristiche dei pazienti deceduti positivi a presente report \u00e8 basato sui dati ggiornati al 13 Marzo 2020 what Persistence of guide UK GPs. healthcare mobile community COVID-19 response The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - on the status. MMR Substantial undocumented infection facilitates the rapid dissemination of novel (SARS-CoV2) Protocolo de ventilaci\u00f3n m\u00faltiple con un solo ventilador para situaciones de pandemia-cat\u00e1strofe sanitaria Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Infographic Comunicado de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN) sobre la enfermedad por COVID-19. -PREVENCI\u00d3N Y VACUNACI\u00d3N: Recomendaciones para el diagn\u00f3stico y tratamiento de eventos tromb\u00f3ticos tras la vacunaci\u00f3n frente a la COVID-19. Documento FACME actualizado a fecha 4 de junio (versi\u00f3n 5). Disponible, aqu\u00ed Sobre las condiciones de riesgo alto de padecer enfermedad grave por COVID-19 y las decisiones de priorizaci\u00f3n de la vacunaci\u00f3n (FACME) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe distancing, face masks, and eye protection to prevent person-to-person Disease and a Tertiary Hospital in Wuhan, China Moving Personal Protective Equipment Into the Community Face Shields and Containment of COVID-19 Hypertension and COVID-19 Safety, tolerability, and immunogenicity open-label, non-randomised, first-in-human trial II Informe OMC Comisi\u00f3n Asesora COVID-19 sobre uso mascarillas en \u00e1mbito sanitario y poblaci\u00f3n general Model of COVID-19: Implications for Prevention, Diagnosis, and Adoption of Preventive Measures for COVID-19: A Pandemic on the use of masks in the context of COVID-19 Vitamin D supplementation could prevent and treat influenza, coronavirus, and workers for COVID-19 response Am I Part of the Cure or Am I Part of the Disease? Keeping Coronavirus Out When a Doctor Comes Home Recomendaciones para Profesionales de Atenci\u00f3n Domiciliaria en Cuidados Paliativos. SECPAL-AECPAL Protocolo de actuaci\u00f3n SPRL COVID-19. Salud Madrid Cuidado emocional del personal sanitario ante el COVID-19 Aclaraciones sobre el uso de mascarillas Personal Sanitario. Precauciones a considerar en su domicilio. -DIAGN\u00d3STICO: Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 Waiting for Certainty on Covid-19 Antibody Tests \u2014 At What Cost? COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? Prognostic Value of Cardiovascular proposed lung ultrasound and phenotypic algorithm for and of a Clinical Risk the Critical Illness the Covid-19 Era \u2014 An Ethical Framework Infectious Diseases Society of America Guidelines on the Diagnosis of Interpreting Diagnostic Tests for SARS-CoV-2 COVID-19 diagnosis management: review Classification of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases IDSA Antibody Testing Primer Covid-19: a remote assessment prognosis of Covid-19 infection: systematic review and critical appraisal Interpretaci\u00f3n de las pruebas diagn\u00f3sticas frente a SARS-CoV-2. Ministerio de Sanidad, SEIMC e ISCIII COVID-19 outbreak: less stethoscope, more dermatologists for diagnosis review and Chest Statement from the Fleischner Society Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province Covid-19: four fifths cases in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 Point-of-Care RNA-Based Diagnostic Device for COVID-19 Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of in acute patients referring to emergency room of and of serological tests in clinical practice Coronavirus in pregnancy and delivery: rapid review Procalcitonin disease Thoracic Radiology, the American College of Radiology, and RSNA Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know Manejo COVID-19. H. Ram\u00e7on y Cajal. Infecciosas Viral load of SARS-CoV-2 in clinical samples Recomendaciones de la Sociedad Espa\u00f1ola de Neurolog\u00eda (SEN) en relaci\u00f3n con la p\u00e9rdida de olfato como posible s\u00edntoma precoz de infecci\u00f3n por CoVID-19 Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. WHO-OMS Utilidad de la ecograf\u00eda pulmonar en la enfermedad COVID-19. Medicina Interna H.U.Torrec\u00e1rdenas Diagnostic Testing for the Novel Coronavirus International Pulmonologist's Consensus on COVID-19 COVID-19 Science Report: RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Chest CT to Predict Adverse in COVID-19 Plan asistencial de Medicina Interna COVID-19. HUCA. 22 de marzo Sistem\u00e1tica de actuaci\u00f3n ante pacientes con PCR negativa y sospecha de infecci\u00f3n por COVID-19. Recomendaciones de la SEORL-CCC para la pr\u00e1ctica de la especialidad durante la pandemia de COVID-19. 22 de marzo. Protocolo de manejo COVID-19. Hospital Universitario de Getafe Gu\u00eda pr\u00e1ctica para el manejo de los pacientes ingresados con infecci\u00f3n por SARS-CoV-2. Hospital General Universitario Gregorio Mara\u00f1\u00f3n Gestaci\u00f3n y coronavirus. Hospital Universitario Central de Asturias Criterio de Atenci\u00f3n Cl\u00ednica y de derivaci\u00f3n hospitalaria de pacientes diagnosticados como casos probables de infecci\u00f3n por SARS-CoV-2 Gu\u00eda b\u00e1sica de indicaciones de pruebas de imagen en la infecci\u00f3n COVID-19 (V1. 21/3/2020) Comunicado de la clinical course with disease York: retrospective case series Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review Cardiovascular disease and COVID-19 Viral and host factors related to the outcome of COVID-19 European Society of the outbreak of disease 2019 (COVID-19) in China Emergency surgery during the COVID-19 pandemic: what you need to know for practice COVID-19 Infection Implications for Perioperative and Critical Care intubated mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China Clinical course and risk factors for surgical care during COVID-19 pandemic A noncompeting pair of human neutralizing antibodies block therapy in patients: Emerging evidence call for Pathological inflammation in patients with a Risk Score Predict the Occurrence of Critical Illness parameters are coronavirus pneumonia Acute myocardial injury Hospitalized COVID-19 China Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During COVID-19 Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Disease (COVID-19) Characteristic CT findings distinguishing 2019 novel coronavirus (COVID-19) pneumonia Association Between Hypoxemia and Mortality and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action Coronavirus Infections and Type 2 Diabetes\u2014Shared Pathways with Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes Viral load dynamics and disease severity in patients 2 Pathways with patients severe COVID-19 Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome Variation in COVID-19 Hospitalizations and Deaths New York City Boroughs Respiratory health in athletes: facing the COVID-19 challenge outcomes COVID-19 and Older Adults: What We Know Coronavirus, COVID-19, SARS Risk Factors Associated With Acute Respiratory Distress Syndrome and in Wuhan, China Prediction for Progression COVID-19 the CALL Score Prediction for Progression in Infection study of 25 fatal cases of COVID-19 in Wuhan Association of Cardiac Injury With Mortality in Hospitalized with Severe Illness Patients with 2019 Coronavirus the Early Stage Gastrointestinal Complications in Critically to Understanding the 2019 Novel Coronavirus Covid-19: four fifths of cases are asymptomatic, China figures indicate Inpatient Care of Patients with COVID-19: A Guide for Hospitalists COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what accuracy different respiratory Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. JAMA Cytokine Storm Syndrome Management of COVID-19 Respiratory patients with Covid-19 disease in New York as silent killer: recent advancement to pathogenesis, therapeutic strategy of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 Wuhan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Coronavirus Disease19 in Geriatrics Long-Term of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington Central nervous system manifestations of COVID-19: A Patients in the New York City Area Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic COVID-19 in Hemodialysis Patients: A Report of 5 Cases COVID-19, cytokines and can for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases Clinical Implications of SARS-Cov2 Interaction with Renin Personnel With SARS-CoV-2 Infection to (COVID-19) infection Clinical Characteristics of Covid-19 in New York City Coronavirus disease 2019 (COVID-19).BMJ Best Practice. The cytokine release syndrome severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality COVID-19 Clinical Trials: A Primer for the Cardiovascular and Communities Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019 Smoking is Associated with COVID-19 Progression: A Meta-Analysis Novel 2019 COVID-19 coagulation parameters are associated with poor prognosis in coronavirus pneumonia with other coronaviruses Coronavirus 9, 2020 \u2014King County, of the U.S. Outbreak Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19c Not Dying Alone \u2014 Modern Compassionate Care in the Covid-19 Pandemic The Variety of Cardiovascular Presentations of COVID-19 Pulmonary and Cardiac Pathology in Covid-19: The Autopsy New Orleans Dysregulation of immune response 2019 (COVID-19): challenges and recommendations Diagnosis and Management of COVID-19 Disease. American Thoracic Society Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies Surviving Sepsis Campaign: Guidelines the Management of Adults with Coronavirus Disease 2019 (COVID-19) COVID-19 China Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 and Pandemic Estimates of the of coronavirus disease 2019: a Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease Acute Acro-ischemia in the child at the time of COVID-19 Practical guidance for the prevention of thrombosis and infected Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus Clinical course of treated With Convalescent Plasma Pluristem Reports Preliminary Data from its Timely blood glucose management for the outbreak of 2019 novel disease COVID-19 or mortality Coronavirus Effects of heart severity: a systematic review and meta-analysis Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China COVID-19 and the ReninQ1 Angiotensin System COVID 19 and the Patient with The Editors Speak Out Clinical considerations for patients with diabetes in times of COVID-19 epidemic COVID-19 and the Heart An algorithm for managing QT prolongation in Coronavirus Pandemic palliative care: beyond ventilators and saving lives Protocolo de manejo y tratamiento de los pacientes cr\u00edticos con neumon\u00eda grave por COVID-19. Hospital Vall d'Hebr\u00f3n Recent advances in the detection of respiratory Review of \"Viral dynamics in mild and severe cases of COVID-19\" Viral dynamics in mild and severe cases of COVID-19 Covid-19 in South Korea \u2014 Challenges Subclinical Manifestations COVID19: Interim Thoracic Societyled International Task Force Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin Blockers in three hospitals within Wuhan, China Urgencia respiratoria en pacientes COVID-19. Hospital Universitario Infanta Cristina Clinical management of severe acute respiratory randomized prospective study Proceso de Atenci\u00f3n al Final de la Vida. Hospital General Universitario Gregorio Mara\u00f1\u00f3n Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death Implications of Fatal Patients With Coronavirus Disease 2019 (COVID-19) Cardiac troponin I in patients with a meta-analysis Pandemic palliative care: beyond ventilators and saving lives Protocolo de manejo cl\u00ednico de los pacientes infectados por Coronavirus CoV-2 (COVID-19). SERGAS. \u00c1rea Sanitaria de Coru\u00f1a y Cee. COVID-19 and Diabetes: can DPP4 inhibition play a role? Effects Questions Enfermedades autoinmunes y COVID-19. Experiencias en el manejo de estos pacientes del Hospital Clinic de Barcelona Liver injury management and challenges Recomendaciones ante una parada cardiaca durante la pandemia de COVID-19 Pragmatic Recommendations for Intubating Critically Ill Patients infections: with Coronavirus Disease 2019 (COVID-19) Cytokines Storm infection and rheumatoid arthritis: Faraway, so close! COVID-19: the new challenge for of Critically Ill Adults With COVID-19 Abnormal coagulation parameters are associated poor prognosis in patients with novel coronavirus pneumonia Physiotherapy Management for COVID-19 in the Acute Hospital Setting: to guide clinical in COVID-19: a sword? Recomendaciones para el manejo de la Miastenia Gravis (MG) y el s\u00edndrome miast\u00e9nico de Lambert-Eaton (LEMS) durante la pandemia de COVID-19 and immunosuppression Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia card\u00edaca, trasplante card\u00edaco y asistencia ventricular. Recomendaciones de la SEC Recomendaciones para manejo de pacientes con infecci\u00f3n por COVID-19 en el contexto de una intervenci\u00f3n quir\u00fargica urgente o electiva. Asociaci\u00f3n Espa\u00f1ola de Cirujanos (AEC) Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infecci\u00f3n por SARSCoV-2 Clinical course and risk factors for mortality of Teleconferencia 10/03/2020 UCI de Lombardia (Milan,Monza,Bergamo,Pavia,Lecco) \u00e1rea de m\u00e1xima difusi\u00f3n de COVID-19 en Italia desde febrero 2020 Clinical management of severe acute Coronavirus Disease 2019 (COVID-19) Clinical Characteristics of Coronavirus 2019 in China. TNEJOM Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State Asymptomatic carrier sobre el abordaje invasivo de la cardiopat\u00eda isqu\u00e9mica y estructural durante el brote de coronavirus COVID-19. Documento de consenso de la Asociaci\u00f3n de Cardiolog\u00eda Intervencionista y la Asociaci\u00f3n de Cardiopat\u00eda Isqu\u00e9mica y Cuidados Agudos Cardiovasculares de la Sociedad Espa\u00f1ola de Cardiolog\u00eda COVID-19 e inhibidores de la enzima convertidora de angiotensina y bloqueadores del receptor from severe acute respiratory syndrome? Recomendaciones del Grupo de Trabajo de VMNI de la Sociedad Espa\u00f1ola de Urgencias y Emergencias respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infecci\u00f3n por SARS-CoV-2 Risk Factors Associated With Acute Respiratory Distress With Coronavirus Disease 2019 Pneumonia in Wuhan, China Gu\u00edas de manejo en terapia intensiva Manejo del SDRA de la Sociedad Catalana de Cr\u00edticos S\u00edndrome de Distr\u00e9s Respiratorio Agudo: Abordaje basado en evidencia Protocolo de atenci\u00f3n a pacientes en situaci\u00f3n de gravedad o \u00faltimos d\u00edas y \u00e9xitus en la crisis del COVID-19. Hospital Universitario La Paz de Madrid. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 COVID-19 in Wuhan, China: a retrospective cohort study Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infecci\u00f3n por SARSCoV-2 -TRATAMIENTO: Proceso Asistencial Integrado para la atenci\u00f3n a las personas afectadas por SARS-CoV-2 (SACYL) Historically controlled comparison of glucocorticoids in patients with COVID-19-associated cytokine of the Patients \u2014 The Cremona experience Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study Hydroxychloroquine or or Prophylaxis of COVID-19: A Living Systematic Review Hydroxychloroquine for the Prevention of Covid-19 \u2014 Searching for Evidence A Randomized Trial of Hydroxychloroquine as for Covid-19 Expression concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19 Anakinra for severe forms of COVID-19: Caution against treatment Considerations in prophylaxis and treatment of VTE in COVID-19 Patients COVID-19 rapid guideline: antibiotics for pneumonia in adults Severe Coronavirus Disease 2019 Potential Role of Vitamin D in the Elderly to Resist and to Slow Progression of Parkinson's Disease Perspective: improving vitamin D status in the management COVID-19 COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19 COVID-19 rapid evidence summary: Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19 COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers Treatment algorithm for COVID-19: a multidisciplinary point of view Review of SARS-CoV-2 and the Ongoing Clinical Trials Ongoing rapid systematic reviews Remdesivir for Treatment of Covid-19 \u2014 Preliminary Report Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry Treatment Algorithm for ADULTS Non-Severe* Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors Direct the pathogenesis COVID-19 a report should be paid to venous thromboembolism prophylaxis in the of COVID-19 Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19) Anticoagulant treatment is associated with decreased Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the hospital with and Mortality in Covid-19 Effect of of Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020 Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options Current Drugs with Potential for Treatment of COVID-19: A Literature Review COVID-19 and its implications for thrombosis and anticoagulation Impact Hospitalized Patients with Covid-19 A Trial of Lopinavir-Ritonavir in Covid-19 Usefulness of Ivermectin in COVID-19 Illness Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With for Coronavirus Disease 2019 (COVID-19) Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine Among Hospitalized Patients Hypercoagulation Antithrombotic Treatment in Coronavirus 2019: A New Challenge Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19 Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidenceand call for action of patients for Innovation Disease 2019 Treatment: A Review of Early and Emerging Options COVID-19 and Thrombotic or Non-Severe COVID-19 Recomendaciones sobre el tratamiento antitrombotico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Espa\u00f1ola de Cardiolog\u00eda Management of COVID-19 Respiratory Distress Current Status of Cell-Based Therapies Therapy for COVID-19: Present or Future Effect of High vs Low Doses of Chloroquine treatment COVID-19 COVID-19. Survival Guide - 1st Edition. McMaster University, Department of Medicine Hamilton, ON, Canada y tratamiento antitromb\u00f3tico en pacientes con COVID-19. SETH Deployment of convalescent plasma for the prevention and treatment of COVID-19 Considerations for Drug Interactions on QTc in Exploratory COVID-19 Research Update Therapies COVID19. University Hospitals Birmingham. SARS-CoV-2 be the Treating COVID-19 Mount Sinai COVID-19 Anticoagulation Algorithm SARS-CoV-2 and COVID-19. Lopinavir-Ritonavir. University of COVID-19. Treatment: Washington. Virus RNA-Dependent RNA Remdesivir Remdesivir, la esperanza antiviral frente al SARS-CoV-2. Espa\u00f1ola de Quimioterapia Remdesivir for coronavirus 2 causing COVID-19: Current knowledge about the antivirals remdesivir (GS-5734) and potential against novel respiratory 2019 coronavirus Remdesivir como potencial terapia frente al COVID-19. Servicio Navarro de Salud Compassionate Use of Remdesivir for Patients with Care Nutrition and Hydration: Key Weapons in the Fight Against COVID-19 Disease COVID-19 therapies No evidence of clinical efficacy of hydroxychloroquine for Covid-19 disease 2019 patients with coagulopathy Protocolo de tromboprofilaxis en pacientes con infecci\u00f3n COVID-19 del Hospital Universitario La Paz de Madrid Clinical Outcomes of Hydroxychloroquine Use of Remdesivir for Patients with Severe Covid-19 Urgent Safety Notice and management of Anticoagulant treatment is associated with decreased mortality in severe coronavirus Infection in Pregnancy Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19 More\" in pneumonia: different respiratory be COVID-19? A review Chloroquine and hydroxychloroquine in Covid-19 Information for Clinicians on Therapeutic Options for Patients with COVID-19 Antihypertensive drugs risk Coronavirus Disease (COVID-19) Collecting and Barrier Enclosure during Endotracheal Intubation Programa de manejo ambulatorio de pacientes con neumon\u00eda COVID-19 leve y bajo riesgo de complicaciones. Hospital Universitario Infanta Cristina Consensus guidelines for managing the airway in patients with of Hydroxychloroquine Chloroquine the Pandemic: What convalescent plasma to treat critically ill patients Manejo de pacientes con COVID19. Hospital Universitario de Getafe Tratamiento Antiviral e Inmunomodulador de la Infecci\u00f3n por SARS-CoV-2. Protocolo HUyP La Fe (Valencia). 2 de marzo de 2020. On the use of corticosteroids for 2019-nCoV pneumonia Covid-19 y personas con enfermedades neuromusculares: Posicionamiento y recomendaciones de la Sociedad Mundial en Enfermedades Musculares (World Muscle Society) Impact of experimental COVID-19 with experimental COVID-19 therapies Evaluating the drug-drug interaction risk of experimental COVID-19 therapies Antimal\u00e1ricos para el tratamiento de COVID-19 YNHHS Treatment of Patients with Confirmed COVID-19 testing for the PICU and general inpatient unit (GIU) Dexamethasone treatment Possibilities and Challenges Plan de trabajo \"Gu\u00eda r\u00e1pida del Protocolo COVID Hospital IFEMA. Marzo de 2020 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Gu\u00eda de tratamiento de adultos con enfermedad por Coronavirus (SARS-CoV-2). Hospital Universitario 12 de Octubre. Versi\u00f3n 9.0 (27 de Marzo de 2020) Clinical and microbiological effect of a combination of hydroxychloroquine and up: an and the At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Revisi\u00f3n del uso de terapias biol\u00f3gicas en el S\u00edndrome de Distress Respiratorio Agudo secundario a la infecci\u00f3n por COVID-19 (SARS-CoV-2) Recomendaciones de fisioterapia respiratoria y ejercicio f\u00edsico para personas afectadas por el COVID-19. CPFCM Declaraci\u00f3n HFSA/ACC/AHA aborda las preocupaciones sobre el uso de antagonistas RAAS en COVID-19 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 Tocilizumab Ventilaci\u00f3n Mec\u00e1nica No Invasiva en COVID-19. Hospital del Henares Tratamiento de la infecci\u00f3n por Coronavirus CoV-2 (COVID-19). Hospital Ram\u00f3n y Cajal F\u00e1rmacos estudiados para combatir el SARS-CoV-2 MGH Treatment Guide for Critically Ill Patients witth COVID-19 Manejo al alta del paciente COVID-19. H.R.U. de M\u00e1laga A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 Hydroxychloroquine and of openlabel non-randomized clinical trial EUSEM Position paper on Emergency Medical Systems response to COVID-19 Gu\u00eda de Tratamiento COVID-19 Hospital 12 de Octubre Fair Allocation of Scarce Medical Resources in the Time of Covid-19. The New England Journal of Medicine The Toughest Triage \u2014 Allocating Ventilators in a Pandemic. The New England Journal of Medicine Massachusetts General Hospital COVID-19 Treatment Guidance Assessment of Evidence for COVID-19-Related COVID-19 Patients with Tocilizumab Manejo farmacol\u00f3gico de trastornos psic\u00f3ticos en personas mayores con tratamiento de la infecci\u00f3n por COVID19: interacciones y recomendaciones terap\u00e9uticas Esquema Terap\u00e9utico Simplificado_ manejo hospitalario de pacientes con infecci\u00f3n confirmada por SARS-CoV-2 en Medicina Interna del HUCA. 22 de marzo de 2020 Tratamiento adultos COVID-19. Hospital Universitario Guadalajara Protocolo tratamiento COVID del Mount Sina\u00ed Gu\u00eda de tratamiento COVID-19 del Hospital Universitario 12 de Octubre Estudio sobre el tratamiento con hidroxicloroquina y a\u00f1adiendo a \u00e9sta azitromicina Esquema de manejo del paciente COVID-19. Hospital Universitario de Fuenlabrada. Covid-19 \u2014 The Search for Effective Therapy. The New England Journal of Medicine Interactions with Experimental COVID-19 Therapies Tratamiento del COVID-19. Osakidetza Tratamiento de la infecci\u00f3n por Coronavirus (COVID-19) CoV-2. Hospital Universitario Ram\u00f3n y Cajal. Versi\u00f3n 2.0 d\u00eda 13 de marzo de 2020 Plan de contingencia para los servicios de Medicina Intensiva frente a la pandemia del COVID-19. SEMICYUC-SEMI -OTROS: Repurposed Antiviral Drugs for Covid-19\u2014Interim WHO Solidarity Trial the Public Back in Public Health \u2014 Surveying Symptoms of Covid-19 Coronavirus disease 2019 (COVID-19): A New Criteria for Lupus excess age: a the collateral virus outbreaks on healthcare workers: rapid review and meta-analysis The Early Natural History of SARS-CoV-2 Infection: Clinical Observations an Patients With COVID-19: Focus on Severity and Mortality Covid-19 \u2014 A Reminder to Reason Coronavirus: The Hammer and the Dance A real-time dashboardof clinical trials for COVID-19 Innovation and Covid-19: Seven Areas Where Clinicians Need to Lead COVID-19: The Worst Days of Our Careers Disease Liberties, and Mass Testing \u2014 Calibrating the Covid-19 Pandemic What I health Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2 Covid-19 and Health Care's Digital Revolution Global coalition to accelerate \u2014 Allocating Ventilators in a Pandemic Consideraciones SEIMC para dar de alta a personal sanitario con COVID-19 Fair Allocation of Scarce Medical Resources in the Time of Covid-19 Certificaciones de Defunci\u00f3n de fallecidos por causas naturales, y en especial en los casos con Covid-19 o sospecha de infecci\u00f3n por Covid-19. OMC. The economics of a pandemic: the case of Covid-19 COVID-19: fighting panic with information Coronavirus: the spread of misinformation The psychological impact of quarantine and how to reduce it: rapid review of the evidence Parenting in a time of COVID-19 The art of medicine COVID-19: the medium is the message mortality and healthcare demand Protocolo para la comunicaci\u00f3n telef\u00f3nica de malas noticias a familiares con Coronavirus en situaci\u00f3n de \u00faltimos d\u00edas. Equipo de Soporte de Cuidados Paliativos del H.U. 12 de Octubre Comunicado de SEMI, semFYC, SEMICYUC y SEPAR sobre MIR ante pandemia COVID-19 "}